Glyphosate Cancer Findings Questioned By New Zealand Health Officials

Health officials in New Zealand indicate that they have been unable to find conclusive evidence that the side effects of exposure to glyphosate, the active ingredient in Monsanto’s popular weed killer Roundup, causes cancer. 

Over the past year, there has been increasing concerns about the potential link between Roundup and cancer, specifically involving the diagnosis of non-Hodgkins lymphoma among farm workers, landscapers and others exposed to high levels of glyphosate.

Concerns have emerged since the World Health Organization’s International Agency for Research on Cancer (IARC) classified glyphosate as a probable human carcinogen in March 2016, sparking a global debate about the widespread use of Roundup and what impact it may have on public health.

ROUNDUP LAWSUITS

Were you or a loved one exposed to RoundUp?

Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin's Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.

Learn More See If You Qualify For Compensation

On August 11, the New Zealand Environmental Protection Authority (EPA) issued a report (PDF) that suggests glyphosate is “unlikely” to be carcinogenic. The findings add to numerous contradictory determinations issued by different health organizations worldwide.

New Zealand researchers say they looked at the IARC’s findings and the studies it reviewed, as well as data assessed by the European Food Safety Authority, which also declared glyphosate to be non-carcinogenic, the U.S. Environmental Protection Agency and other groups.

“The majority of human studies did not show an association between exposure to glyphosate and cancer,” the report’s lay summary (PDF) states. “Although a small number of studies with a limited number of participants found a weak association between glyphosate exposure and increased risk of non-Hodgkin lymphoma (NHL), others did not.”

The IARC has repeatedly defended its science against the health administrations of other countries, which have approved the widespread use of Roundup and other glyphosate-based pesticides for decades, some say with little scrutiny.

“The review confirms the EPA’s long-held findings that at the present time glyphosate – with controls – is safe to use,” Ray McMillan, acting General Manager of the New Zealand EPA’s Hazardous Substances and New Organisms team said in a press release. “As with any chemical, glyphosate remains subject to our approval process which considers any likely impacts on human health and the environment.”

The findings come amid a growing number of Roundup cancer lawsuits being filed in the U.S. Plaintiffs in the agricultural industry who have worked with Roundup for years say they developed non-Hodgkin lymphoma after regular, repeated exposure, just as the IARC predicted. The complaints accuse Monsanto of failing to warn the agriculture industry or medical community of the true risks of Roundup, even as it came to dominate the herbicide market.

An estimated 2.6 billion pounds of the herbicide have been sprayed on America’s agricultural land over the two decades, since Monsanto introduced “Roundup Ready” crops that are designed to survive being sprayed with with the chemical, killing the weeds but not the crops.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025
Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025 (Posted yesterday)

A series of four bellwether claims in the baby formula NEC lawsuit MDL will be ready to go before a federal juries in May 2025, August 2025, November 2025 and February 2026 according to a proposed trial schedule agreed upon by both plaintiffs and defendants.

AngioDynamics Port Catheter Lawsuit MDL Established in Southern District of California
AngioDynamics Port Catheter Lawsuit MDL Established in Southern District of California (Posted 2 days ago)

U.S. JPML has transferred all AngioDynamics port catheter lawsuits to the U.S. District Court for the Southern District of California, for coordinated discovery and pretrial proceedings as part of a federal MDL (multidistrict litigation).